FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly an oral compound containing a pharmaceutical agent and coated with one layer of a film-forming polymer. Specified coating contains at least two mixed spacer agents wherein at least one spacer agent is a soap, at least one spacer agent is layer silicate, while the film-forming polymer is polyacrylate.
EFFECT: there is disclosed coated compound containing the pharmaceutical agent.
25 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL FILM COATING | 2002 |
|
RU2323717C2 |
| MEDICINAL RETARD-FORMULATION CONTAINING TRAMADOL SACCHARINATE | 2000 |
|
RU2292877C2 |
| PHARMACEUTICAL COMPOSITION OF OMEPRAZOL | 2012 |
|
RU2647472C2 |
| SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING RIVASTIGMINE | 2016 |
|
RU2727721C2 |
| APPLICATION OF ANDROGRAPHOLIDE IN PREPARATION OF PHARMACEUTICAL DRUG FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE, ANDROGRAPHOLIDE ENTERIC TARGETING MICROPELLET, AND METHOD FOR PREPARATION THEREOF | 2014 |
|
RU2681930C2 |
| PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
| PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE ACTIVE SUBSTANCE | 2004 |
|
RU2447884C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| STABILISATION OF PROFILE OF ACTIVE SUBSTANCE RELEASE FROM MEDICINAL FORM | 2003 |
|
RU2354387C2 |
